跳至主要内容
临床试验/ISRCTN10248064
ISRCTN10248064已完成2 期

Intermittent high dose AmBisome® on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: An adaptive randomized controlled non-inferiority trial

St George's University of London (UK)0 个研究点目标入组 80 人开始时间: 2014年1月22日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Consecutive patients (male and female) aged > 18 years with a first episode of cryptococcal meningitis (CSF India ink or CrAg test)
  • 2. Known to be HIV positive or willing to undertake an HIV test
  • 3. Willing to agree to participate in the study

排除标准

  • 1. Pregnancy or lactation
  • 2. Previous serious reaction to study drugs
  • 3. Already taking antifungals for >48 hours
  • 4. Concomitant medication that is contraindicated with study drugs

研究者

发起方
St George's University of London (UK)

相似试验